Simplexa C. Difficile Universal Direct
C. Difficile Nucleic Acid Amplification Test Assay. 510(k) K113433, from Focus Diagnostics, Inc. (Cypress, CA). Product code OMN, class 1.
As of Nov 21, 2026, K113433 is an FDA 510(k) held by Focus Diagnostics, Inc., substantially equivalent on Apr 4, 2012 after 135 days, with no recalls tied to it in FDA's recall database.
- Review time: 135 days
- Recalls: 0
The Focus Diagnostics Simplexaâ„¢ C. difficile Universal Direct is a real-time polymerase chain reaction (PCR) assay and is intended for use on the 3M Integrated Cycler instrument for the detection of toxigenic Clostridium difficile toxin B gene (tcdB) in liquid or unformed stool samples from individuals suspected of C. difficile infection.
- Illumigene C. Difficile, and Illumipro-10K110012 · Meridian Bioscience, Inc. · Feb 24, 2011
- BD Geneohm Cdiff AssayK081920 · Bd Diagnostics (Geneohm Sciences, Inc.) · Dec 19, 2008
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 21, 2011
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.2660
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files